{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:09:01Z","timestamp":1788772141206,"version":"build-2803163510"},"reference-count":6,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>A 64-year-old woman was referred with a suspected melanoma recurrence at her left shin skin graft site. She had a background of stage IIIC melanoma, which was initially managed with wide local excision and split-skin graft from the right thigh and healed without complication. She then commenced 4-weekly adjuvant nivolumab and after her fifth cycle, positron emission tomography imaging revealed increased FDG uptake at the graft site. An associated abnormal skin change over the graft site was noted by the Oncology team.<\/jats:p>","DOI":"10.1093\/ced\/llag306","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:43:58Z","timestamp":1784202238000},"source":"Crossref","is-referenced-by-count":0,"title":["Not every purple plaque is recurrence: a striking skin eruption on a melanoma skin graft site"],"prefix":"10.1093","author":[{"given":"Emily","family":"Lloyd","sequence":"first","affiliation":[{"name":"University Hospitals Dorset NHS Foundation Trust , Dorset ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellen","family":"Beck-Sander","sequence":"additional","affiliation":[{"name":"University Hospitals Dorset NHS Foundation Trust , Dorset ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie","family":"Chong","sequence":"additional","affiliation":[{"name":"University Hospitals Dorset NHS Foundation Trust , Dorset ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Belgi","sequence":"additional","affiliation":[{"name":"University Hospitals Dorset NHS Foundation Trust , Dorset ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"2026090704220302900_llag306-B1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/ijms26010088","article-title":"Immune checkpoint inhibitor-associated cutaneous adverse events: mechanisms of occurrence","volume":"26","author":"Eshaq","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026090704220302900_llag306-B2","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026090704220302900_llag306-B3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/ijerph20010580","article-title":"Risk of lichen sclerosus and lichen planus in patients receiving immune checkpoint inhibitors","volume":"20","author":"Alharbi","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026090704220302900_llag306-B4","first-page":"e86862","article-title":"Nivolumab-induced lichenoid eruption: a case report","volume":"17","author":"Leme","year":"2025","journal-title":"Cureus"},{"key":"2026090704220302900_llag306-B5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2340\/00015555-2545","article-title":"Lichen planus in irradiated skin during nivolumab treatment","volume":"97","author":"Komori","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"2026090704220302900_llag306-B6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/dermatopathology10020023","article-title":"A clinico-pathological multidisciplinary team increases the efficacy of skin biopsy and reduces clinical risk in dermatology","volume":"10","author":"Tomasini","year":"2023","journal-title":"Dermatopathology (Basel)"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag306\/69138326\/llag306.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag306\/69138326\/llag306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:22:08Z","timestamp":1788769328000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/advance-article\/doi\/10.1093\/ced\/llag306\/8736368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":6,"URL":"https:\/\/doi.org\/10.1093\/ced\/llag306","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"llag306"}}